000 01604 a2200481 4500
005 20250516110017.0
264 0 _c20130107
008 201301s 0 0 eng d
022 _a0004-4172
024 7 _a10.1055/s-0032-1321848
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCánovas, M
245 0 0 _aBioequivalence study of 2 orodispersible formulations of zolmitriptan 5 mg in healthy volunteers.
_h[electronic resource]
260 _bArzneimittel-Forschung
_cOct 2012
300 _a482-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aArea Under Curve
650 0 4 _aChemistry, Pharmaceutical
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aCross-Over Studies
650 0 4 _aDatabases, Factual
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOxazolidinones
_xadministration & dosage
650 0 4 _aSerotonin Receptor Agonists
_xadministration & dosage
650 0 4 _aTablets
650 0 4 _aTandem Mass Spectrometry
650 0 4 _aTherapeutic Equivalency
650 0 4 _aTryptamines
_xadministration & dosage
650 0 4 _aYoung Adult
700 1 _aCanals, M
700 1 _aPolonio, F
700 1 _aCabré, F
773 0 _tArzneimittel-Forschung
_gvol. 62
_gno. 10
_gp. 482-6
856 4 0 _uhttps://doi.org/10.1055/s-0032-1321848
_zAvailable from publisher's website
999 _c22048925
_d22048925